The global pharmaceutical manufacturing market, rising at a CAGR) of 7.63% is projected to be valued at $929.9B by 2030, according to a report by Research & Markets. This growth is driven by several factors, including technological advancements, cost-effective methods, and increased investments in the pharmaceutical industry.
Integration of AI and robotics, the adoption of disposable solutions, and data-rich operations are enhancing efficiency and quality in pharmaceutical manufacturing. Additionally, the shift towards patient-centric healthcare models is prompting manufacturers to adjust their supply chains. Oral solid dosage forms (OSDs)--especially tablets–will continue to dominate the market.